Global Cardiac Resynchronization Therapy (CRT) Devices Market – Analysis By Product (CRT-D, CRT-P), End-User By Region, By Country (2022 Edition): Market Insights and Forecast with Impact of COVID-19 (2022-2027)

Global Cardiac Resynchronization Therapy (CRT) Devices Market – Analysis By Product (CRT-D, CRT-P), End-User By Region, By Country (2022 Edition): Market Insights and Forecast with Impact of COVID-19 (2022-2027)

Executive Summary

The Global Cardiac Resynchronization Therapy (CRT) Devices Market was valued at USD 7.14 Billion in the year 2021 with the Americas region leading the regional market share. One of the main factors driving this market is the rising prevalence of cardiovascular diseases (CVDs) that lead to heart failure (HF). Each year, approximately 3.5 million people suffer from HF worldwide fostering the demand for cardiac resynchronization therapy devices. Additionally, factors such as technological advancements in devices, expanding CRT product developments, key company initiatives & investments, sedentary lifestyles and ageing demographics around the world are anticipated to impel the market growth in the forecast period.

The Asia Pacific CRT devices market is predicted to be the hotspot and the most lucrative region for the market participants worldwide. Some of the major factors propelling the growth of the cardiac resynchronization therapy devices market in the Asia Pacific region include a favourable reimbursement scenario in Japan, an ageing population in China, an increase in CVD incidence, an improved healthcare infrastructure, an expanding middle-class population, and rising disposable income levels in India.

The cardiac resynchronization therapy (CRT) devices market experienced a period of a temporary setback in the year 2020 as lockdown restrictions were enforced as a necessary step to curb the spread of COVID-19 virus. However, after the initial shock and confusion about COVID-19, companies and governments began taking corrective actions to help the economy and businesses recover. These measures included policy & monetary stimulus, easing of restrictions, conditional exemptions, and other strategic initiatives. This resulted in healthcare activities returning to normal pace towards the end of 2020 with the approval and administration of COVID-19 vaccines across the globe, thereby offering better growth prospects for the cardiac resynchronization therapy devices market during the forecast period.

Scope of the Report

  • The report analyses the Cardiac Resynchronization Therapy Devices Market by Value (USD Billion).
  • The report analyses the Cardiac Resynchronization Therapy Devices Market by Volume (in Million Units).
  • The report analyses the Cardiac Resynchronization Therapy Devices Market by Product (CRT-Defibrillator and CRT-Pacemaker)
  • The report analyses the Cardiac Resynchronization Therapy Devices Market by End User (Hospitals, Cardiac Centers and Research & Laboratories)
  • The Global Cardiac Resynchronization Therapy Devices Market has been analysed By Region (Americas, Europe, Asia Pacific, MEA).
  • The Global Cardiac Resynchronization Therapy Devices Market has been analysed By Country (United States, Canada, Germany, United Kingdom, France, Italy, Spain, China, Japan, India).
  • The key insights of the report have been presented through the leading company shares. Also, the attractiveness of the market has been presented by region, by Product and by End User.
  • Also, the major opportunities, trends, drivers and challenges of the industry has been analysed in the report.
  • The report tracks competitive developments, strategies, and Major Products & Developments and Mergers & Acquisitions. The companies analysed in the report include Medtronic, Boston Scientific Corp., Abbott Laboratories, Biotronik, MicroPort Scientific Corporation, Medico S.p.A, LivaNova and EBR Systems.
  • The report presents the analysis of the Cardiac Resynchronization Therapy Devices Market for the historical period of 2017-2021 and the forecast period of 2022-2027.
Key Target Audience
  • Cardiac Resynchronization Therapy Devices Manufacturers & Distributors
  • End Users (Hospitals, Cardiac Centers, Research & Laboratories)
  • Research and Development (R&D) Organizations
  • Government Bodies & Regulating Authorities
  • Investment Banks and Equity Firms


1. Report Scope and Methodology
1.1 Scope of the Report
1.2 Research Methodology
1.3 Executive Summary
2. Strategic Recommendations
3. Global Cardiac Resynchronization Therapy Devices Market: Product Overview
4. Global Cardiac Resynchronization Therapy Devices Market: An Analysis
4.1. Assessment of Macro Economic Indicators of Global Cardiac Resynchronization Therapy Devices Market
Table 1: Global GDP per capita (2018-2020) In USD Thousands
Table 2: Global Aged Population (Above 65), 2017-21 (% of total Population)
Table 3: Global Aged Population (Above 65), By Country, 2021 (% of total Population, roundoff)
Table 4: Global Medical Spending in 2020, By Region, (% of Total)
Table 5: Global Prevalence of Cardiovascular Diseases, (in million), 2015-2019
Table 6: Current Healthcare Expenditure (% Share of GDP), By Selected Country, 2016-2020 (In %)
Table 7: Global Expected Healthcare Industry Outlook
Table 8: Regional Expected Healthcare Industry Growth Rate By Year, 2024
4.2 Global Cardiac Resynchronization Therapy Devices Market, Market Size, By Value, 2017-2027
Table 9: Global Cardiac Resynchronization Therapy Devices Market Size, By Value, 2017-2027 (USD Billion)
4.3 Global Cardiac Resynchronization Therapy Devices Market, Market Size, By Volume, (Million Units), 2017-2027
Table 10: Global Cardiac Resynchronization Therapy Devices Market Size, By Volume (Million Units), 2017-2027
4.4 Global Cardiac Resynchronization Therapy Devices Market: Growth and Forecast
4.5 Impact of COVID-19 on Global Cardiac Resynchronization Therapy Devices Market
5. Global Cardiac Resynchronization Therapy Devices Market: Segmental Analysis
5.1 Global Cardiac Resynchronization Therapy Devices Market Segmentation, By Product
5.2 Competitive Positioning of Cardiac Resynchronization Therapy Devices Market: By Product (2021 & 2027)
Table 11: Global Cardiac Resynchronization Therapy Devices Market- By Product Market Share, 2021 & 2027
5.3 By CRT-Defibrillator, By Value (USD Billion), 2017-2027
Table 12: Global Cardiac Resynchronization Therapy Devices Market- By Product, By CRT-Defibrillator, By Value (USD Billion), 2017-2027
5.4 By CRT-Pacemaker, By Value (USD Billion), 2017-2027
Table 13: Global Cardiac Resynchronization Therapy Devices Market- By Product, By CRT-Pacemaker, By Value (USD Billion), 2017-2027
6. Global Cardiac Resynchronization Therapy Devices Market: Segment Analysis
6.1 Global Cardiac Resynchronization Therapy Devices Market Segmentation, By End-User
6.2 Competitive Positioning of Global Cardiac Resynchronization Therapy Devices Market, By End-User (2021 & 2027)
Table 14: Global Cardiac Resynchronization Therapy Devices Market- By End-User Market Share, 2021 & 2027
6.3 By Hospitals, By value (USD Billion), 2017-2027
Table 15: Global Cardiac Resynchronization Therapy Devices Market- By End-User, By Hospitals, By Value (USD Billion), 2017-2027
6.4 By Cardiac Centers, By Value (USD Billion), 2017-2027
Table 16: Global Cardiac Resynchronization Therapy Devices Market- By End-User, By Cardiac Centers, By Value (USD Billion), 2017-2027
6.5 By Research & Laboratories, By Value (USD Billion), 2017-2027
Table 17: Global Cardiac Resynchronization Therapy Devices Market- By End-User, By Research & Laboratories, By Value (USD Billion), 2017-2027
7. Global Cardiac Resynchronization Therapy Devices Market: Regional Analysis
7.1 Competitive Positioning of Global Cardiac Resynchronization Therapy Devices Market: By Region (2021 & 2027)
Table 18: Global Cardiac Resynchronization Therapy Devices Market- By Region Market Share, 2021 & 2027
8. Americas Cardiac Resynchronization Therapy Devices Market: An Analysis (2017-2027)
8.1 Assessment of Macro Economic Indicators of Americas Cardiac Resynchronization Therapy Devices Market
Table 19: Americas Population (in Millions), 2018-2021
Table 20: North America Population ages 65 and above (% of total Population), 2017-21
Table 21: Latin America & Caribbean Population ages 65 and above (% of total Population), 2017-21
Table 22: Current health expenditure per capita in the U.S. and Canada (current USD), 2020
Table 23: Prevalence of Cardiovascular Diseases in Americas, (in million), 2015-2019
Table 24: Americas Diabetes Prevalence, By Country, 2021 (in million)
Table 25: Prevalence of Heart Failure in the U.S. & Canada (% of the population), 2020
8.2 Americas Cardiac Resynchronization Therapy Devices Market- Size and Forecast, By Value (2017-2027)
Table 26: Americas Cardiac Resynchronization Therapy Devices Market Size, By Value, 2017-2027 (USD Billion)
8.3 Americas Cardiac Resynchronization Therapy Devices Market: Prominent Companies
8.4 Americas Cardiac Resynchronization Therapy Devices Market: Segment Analysis
8.5 Americas Cardiac Resynchronization Therapy Devices Market By Product (CRT-Defibrillator and CRT-Pacemaker)
Table 27: Americas Cardiac Resynchronization Therapy Devices Market- By Product, By Value (USD Billion), 2017-2027
8.6 Americas Cardiac Resynchronization Therapy Devices Market By End-User (Hospitals, Cardiac Centers and Research & Laboratories)
Table 28: Americas Cardiac Resynchronization Therapy Devices Market- By End-User, By Value (USD Billion), 2017-2027
8.7 Americas Cardiac Resynchronization Therapy Devices Market: Country Analysis
8.8 Market Opportunity Chart of Americas Cardiac Resynchronization Therapy Devices Market - By Country, By Value (Year-2027)
Table 29: Market Opportunity Chart of Americas Cardiac Resynchronization Therapy Devices Market- By Country, By Value (Year-2027)
8.9 Competitive Positioning of Americas Cardiac Resynchronization Therapy Devices Market - By Country
Table 30: Americas Cardiac Resynchronization Therapy Devices Market- By Country Market Share, 2021 & 2027
8.10 United States Cardiac Resynchronization Therapy Devices Market: Size and Forecast, By Value (2017-2027)
Table 31: United States Cardiac Resynchronization Therapy Devices Market Size, By Value, 2017-2027 (USD Billion)
8.11 United States Cardiac Resynchronization Therapy Devices Market By Product and By End-User, By Value (2017-2027)
Table 32: United States Cardiac Resynchronization Therapy Devices Market- By Product, By Value (USD Billion), 2017-2027
Table 33: United States Cardiac Resynchronization Therapy Devices Market- By End-User, By Value (USD Billion), 2017-2027
8.12 Canada Cardiac Resynchronization Therapy Devices Market: Size and Forecast, By Value (2017-2027)
Table 34: Canada Cardiac Resynchronization Therapy Devices Market Size, By Value, 2017-2027 (USD Billion)
8.13 Canada Cardiac Resynchronization Therapy Devices Market By Product and By End-User, By Value (2017-2027)
Table 35: Canada Cardiac Resynchronization Therapy Devices Market- By Product, By Value (USD Billion), 2017-2027
Table 36: Canada Cardiac Resynchronization Therapy Devices Market- By End-User, By Value (USD Billion), 2017-2027
9. Europe Cardiac Resynchronization Therapy Devices Market: An Analysis (2017-2027)
9.1 Assessment of Macro Economic Indicators of Asia Pacific Cardiac Resynchronization Therapy Devices Market
Table 37: European Union Population (in Millions), 2018-2021
Table 38: Population ages 65 and above (% of total Population) in European Countries, 2020
Table 39: European Union Current health expenditure per capita (current USD), 2015-19
Table 40: Country wise healthcare expenditure in Europe (% of GDP), 2020
Table 41: European Union GDP Per Capita, value (USD Billion), 2018-20
Table 42: Europe Prevalence of Cardiovascular Diseases (in Million), 2015-2019
Table 43: Europe Diabetes Prevalence, By Country, 2021 (in million)
9.2 Europe Cardiac Resynchronization Therapy Devices Market- Size and Forecast, By Value (2017-2027)
Table 44: Europe Cardiac Resynchronization Therapy Devices Market Size, By Value, 2017-2027 (USD Billion)
9.3 Europe Cardiac Resynchronization Therapy Devices Market: Prominent Companies
9.4 Europe Cardiac Resynchronization Therapy Devices Market: Segment Analysis
9.5 Europe Cardiac Resynchronization Therapy Devices Market By Product (CRT-Defibrillator and CRT-Pacemaker), By Value, 2017-2027
Table 45: Europe Cardiac Resynchronization Therapy Devices Market- By Product, By Value (USD Billion), 2017-2027
9.6 Europe Cardiac Resynchronization Therapy Devices Market By End-User (Hospitals, Cardiac Centers and Research & Laboratories), By Value, 2017-2027
Table 46: Europe Cardiac Resynchronization Therapy Devices Market- By End-User, By Value (USD Billion), 2017-2027
9.7 Europe Cardiac Resynchronization Therapy Devices Market: Country Analysis
9.8 Market Opportunity Chart of Europe Cardiac Resynchronization Therapy Devices Market - By Country, By Value (Year-2027)
Table 47: Market Opportunity Chart of Europe Cardiac Resynchronization Therapy Devices Market- By Country, By Value (Year-2027)
9.9 Competitive Positioning of Europe Cardiac Resynchronization Therapy Devices Market - By Country
Table 48: Europe Cardiac Resynchronization Therapy Devices Market- By Country Market Share, 2021 & 2027
9.10 Germany Cardiac Resynchronization Therapy Devices Market: Size and Forecast, By Value (2017-2027)
Table 49: Germany Cardiac Resynchronization Therapy Devices Market Size, By Value, 2017-2027 (USD Billion)
9.11 Germany Cardiac Resynchronization Therapy Devices Market By Product and By End-User, By Value (2017-2027)
Table 50: Germany Cardiac Resynchronization Therapy Devices Market- By Product, By Value (USD Billion), 2017-2027
Table 51: Germany Cardiac Resynchronization Therapy Devices Market- By End-User, By Value (USD Billion), 2017-2027
9.12 United Kingdom Cardiac Resynchronization Therapy Devices Market: Size and Forecast, By Value (2017-2027)
Table 52: United Kingdom Cardiac Resynchronization Therapy Devices Market Size, By Value, 2017-2027 (USD Billion)
9.13 United Kingdom Cardiac Resynchronization Therapy Devices Market By Product and By End-User, By Value (2017-2027)
Table 53: United Kingdom Cardiac Resynchronization Therapy Devices Market- By Product, By Value (USD Billion), 2017-2027
Table 54: United Kingdom Cardiac Resynchronization Therapy Devices Market- By End-User, By Value (USD Billion), 2017-2027
9.14 France Cardiac Resynchronization Therapy Devices Market: Size and Forecast, By Value (2017-2027)
Table 55: France Cardiac Resynchronization Therapy Devices Market Size, By Value, 2017-2027 (USD Billion)
9.15 France Cardiac Resynchronization Therapy Devices Market By Product and By End-User, By Value (2017-2027)
Table 56: France Cardiac Resynchronization Therapy Devices Market- By Product, By Value (USD Billion), 2017-2027
Table 57: France Cardiac Resynchronization Therapy Devices Market- By End-User, By Value (USD Billion), 2017-2027
9.16 Italy Cardiac Resynchronization Therapy Devices Market: Size and Forecast, By Value (2017-2027)
Table 58: Italy Cardiac Resynchronization Therapy Devices Market Size, By Value, 2017-2027 (USD Billion)
9.17 Italy Cardiac Resynchronization Therapy Devices Market By Product and By End-User, By Value (2017-2027)
Table 59: Italy Cardiac Resynchronization Therapy Devices Market- By Product, By Value (USD Billion), 2017-2027
Table 60: Italy Cardiac Resynchronization Therapy Devices Market- By End-User, By Value (USD Billion), 2017-2027
9.18 Spain Cardiac Resynchronization Therapy Devices Market: Size and Forecast, By Value (2017-2027)
Table 61: Spain Cardiac Resynchronization Therapy Devices Market Size, By Value, 2017-2027 (USD Billion)
9.19 Spain Cardiac Resynchronization Therapy Devices Market By Product and By End-User, By Value (2017-2027)
Table 62: Spain Cardiac Resynchronization Therapy Devices Market- By Product, By Value (USD Billion), 2017-2027
Table 63: Spain Cardiac Resynchronization Therapy Devices Market- By End-User, By Value (USD Billion), 2017-2027
10. Asia Pacific Cardiac Resynchronization Therapy Devices Market: An Analysis (2017-2027)
10.1 Assessment of Macro Economic Indicators of Asia Pacific Cardiac Resynchronization Therapy Devices Market
Table 64: Asia Pacific, Population ages 65 and above (% of total Population), 2016-20
Table 65: Asia Pacific Population ages 65 and above, by Countries (% of total Population), 2020
Table 66: Asia Pacific Current health expenditure per capita (current USD), 2014-18
Table 67: Asia Pacific, Current health expenditure per capita, by countries (current USD), 2019
Table 68: East Asia and Pacific Population (in Billion), 2018-2020
Table 69: Prevalence of Cardiovascular Diseases in Asia Pacific, (in million), 2015-2019
Table 70: Asia Pacific Diabetes Prevalence, By Country, 2020 (% of Population Age 20 to 79)
10.2 Asia Pacific Cardiac Resynchronization Therapy Devices Market- Size and Forecast, By Value (2017-2027)
Table 71: Asia Pacific Cardiac Resynchronization Therapy Devices Market Size, By Value, 2017-2027 (USD Billion)
10.3 Asia Pacific Cardiac Resynchronization Therapy Devices Market: Prominent Companies
10.4 Asia Pacific Cardiac Resynchronization Therapy Devices Market: Segment Analysis
10.5 Asia Pacific Cardiac Resynchronization Therapy Devices Market By Product, (CRT-Defibrillator and CRT-Pacemaker)
Table 72: Asia Pacific Cardiac Resynchronization Therapy Devices Market- By Product, By Value (USD Billion), 2017-2027
10.6 Asia Pacific Cardiac Resynchronization Therapy Devices Market By End-User (Hospitals, Cardiac Centers and Research & Laboratories), By Value
Table 73: Asia Pacific Cardiac Resynchronization Therapy Devices Market- By End-User, By Value (USD Billion), 2017-2027
10.7 Asia Pacific Cardiac Resynchronization Therapy Devices Market: Country Analysis
10.8 Market Opportunity Chart of Asia Pacific Cardiac Resynchronization Therapy Devices Market - By Country, By Value (Year-2027)
Table 74: Market Opportunity Chart of Europe Cardiac Resynchronization Therapy Devices Market- By Country, By Value (Year-2027)
10.9 Competitive Positioning of Asia Pacific Cardiac Resynchronization Therapy Devices Market - By Country
Table 75: Asia Pacific Cardiac Resynchronization Therapy Devices Market- By Country Market Share, 2021 & 2027
10.10 China Cardiac Resynchronization Therapy Devices Market: Size and Forecast, By Value (2017-2027)
Table 76: China Cardiac Resynchronization Therapy Devices Market Size, By Value, 2017-2027 (USD Billion)
10.11 China Cardiac Resynchronization Therapy Devices Market By Product and By End-User, By Value (2017-2027)
Table 77: China Cardiac Resynchronization Therapy Devices Market- By Product, By Value (USD Billion), 2017-2027
Table 78: China Cardiac Resynchronization Therapy Devices Market- By End-User, By Value (USD Billion), 2017-2027
10.12 Japan Cardiac Resynchronization Therapy Devices Market: Size and Forecast, By Value (2017-2027)
Table 79: Japan Cardiac Resynchronization Therapy Devices Market Size, By Value, 2017-2027 (USD Billion)
10.13 Japan Cardiac Resynchronization Therapy Devices Market By Product and By End-User, By Value (2017-2027)
Table 80: Japan Cardiac Resynchronization Therapy Devices Market- By Product, By Value (USD Billion), 2017-2027
Table 81: Japan Cardiac Resynchronization Therapy Devices Market- By End-User, By Value (USD Billion), 2017-2027
10.14 India Cardiac Resynchronization Therapy Devices Market: Size and Forecast, By Value (2017-2027)
Table 82: India Cardiac Resynchronization Therapy Devices Market Size, By Value, 2017-2027 (USD Billion)
10.15 India Cardiac Resynchronization Therapy Devices Market By Product and By End-User, By Value (2017-2027)
Table 83: India Cardiac Resynchronization Therapy Devices Market- By Product, By Value (USD Billion), 2017-2027
Table 84: India Cardiac Resynchronization Therapy Devices Market- By End-User, By Value (USD Billion), 2017-2027
11. MEA Cardiac Resynchronization Therapy Devices Market: An Analysis (2017-2027)
11.1 Assessment of Macro Economic Indicators of MEA Cardiac Resynchronization Therapy Devices Market
Table 85: Middle East and North Africa Population (in Million), 2018-2020
Table 86: Middle East & North Africa, Current health expenditure per capita (current USD), 2016-19
Table 87: Prevalence of Cardiovascular Diseases in Middle East & North Africa, (in million), 2015-2019
Table 88: Middle East & North Africa, Current health expenditure per capita (% of GDP), 2016-19
11.2 MEA Cardiac Resynchronization Therapy Devices Market- Size and Forecast, By Value (2017-2027)
Table 89: MEA Cardiac Resynchronization Therapy Devices Market Size, By Value, 2017-2027 (USD Billion)
11.3 MEA Cardiac Resynchronization Therapy Devices Market By Product, (CRT-Defibrillator and CRT-Pacemaker)
Table 90: MEA Cardiac Resynchronization Therapy Devices Market- By Product, By Value (USD Billion), 2017-2027
11.4 MEA Cardiac Resynchronization Therapy Devices Market By End-User (Hospitals, Cardiac Centers and Research & Laboratories), By Value
Table 91: MEA Cardiac Resynchronization Therapy Devices Market- By End-User, By Value (USD Billion), 2017-2027
12. Global Cardiac Resynchronization Therapy Devices Market Dynamics
12.1 Global Cardiac Resynchronization Therapy Devices Market Drivers
12.2 Global Cardiac Resynchronization Therapy Devices Market Restraints
12.3 Global Cardiac Resynchronization Therapy Devices Market Trends
13. Market Attractiveness and Strategic Analysis
13.1 Market Attractiveness Chart of Global Cardiac Resynchronization Therapy Devices Market - By Product (Year 2027)
Table 92: Market Attractiveness Chart of Global Cardiac Resynchronization Therapy Devices Market- By Product (Year-2027)
13.2 Market Attractiveness Chart of Global Cardiac Resynchronization Therapy Devices Market - By End-User (Year 2027)
Table 93: Market Attractiveness Chart of Global Cardiac Resynchronization Therapy Devices Market- By End-User (Year-2027)
13.3 Market Attractiveness Chart of Global Cardiac Resynchronization Therapy Devices Market - By Region (Year 2027)
Table 94: Market Attractiveness Chart of Global Cardiac Resynchronization Therapy Devices Market- By Region (Year-2027)
14. Competitive Landscape
14.1 Market Share of global leading companies
Table 95: Global Cardiac Resynchronization Therapy Devices Market Share (%), 2021
14.2 Recent Developments and Mergers & Acquisitions
14.3 Prominent Companies Worldwide Unit Sales of CRT Devices in FY 2021
Table A: Prominent Companies Worldwide Unit Sales of CRT Devices in FY 2021
15. Company Profiles (Business Description, Financial Analysis, Business Strategy)
15.1 Medtronic PLC
Table 96: Medtronic Annual Sales Revenue, 2018-2022 (USD Million)
Table 97: Medtronic Net Income, 2018-2022 (USD Million)
Table 98: Medtronic Sales Revenue, By Business Segment (%), FY2022
Table 99: Medtronic Sales Revenue, By Geographical Segment (%), FY2022
15.2 Boston Scientific
Table 100: Boston Scientific Annual Sales Revenue, 2017-2021 (USD Million)
Table 101: Boston Scientific Net Income, 2017-2021 (USD Million)
Table 102: Boston Scientific Sales Revenue, By Business Segment (%), FY2021
Table 103: Boston Scientific Sales Revenue, By Geographical Segment (%), FY2021
15.3 Abbott Laboratories
Table 104: Abbott Laboratories Sales Revenue, 2017-2021 (USD Million)
Table 105: Abbott Laboratories Net Income, 2017-2021 (USD Million)
Table 106: Abbott Laboratories Sales Revenue, By Business Segment (%), FY2021
Table 107: Abbott Laboratories Sales Revenue, By Geographical Segment (%), FY2021
15.4 Biotronik
15.5 MicroPort Scientific Corporation
Table 108: MicroPort Scientific Corporation Annual Sales Revenue, 2017-2021 (USD Million)
Table 109: MicroPort Scientific Corporation Net Income, 2017-2021 (USD Million)
Table 110: MicroPort Scientific Corporation Sales Revenue, By Business Segment (%), FY2021
Table 111: MicroPort Scientific Corporation Sales Revenue, By Geographical Segment (%), FY2021
15.6 LivaNova PLC
Table 112: LivaNova PLC Annual Sales Revenue, 2016-2021 (USD Million)
Table 113: LivaNova PLC Net Income, 2016-2021 (USD Million)
Table 114: LivaNova PLC, Sales Revenue, By Business Segment (%), FY2021
Table 115: LivaNova PLC, Sales Revenue, By Geographical Segment (%), FY2021
15.7 Medico S.p.A
15.8 EBR Systems

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings